骨质疏松症新型冠状病毒感染临床应对指南

doi:10.16138/j.1673-6087.2023.01.007

摘要/Abstract

中图分类号:

R683
R511

中华医学会内分泌学分会. 骨质疏松症新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 22-24.

Chinese Society of Endocrinology. Guidelines for clinical management of novel coronavirus infection in osteoporosis[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(01): 22-24.

参考文献 22

[1]	Berktaçs BM, Gökçek A, Hoca NT, et al. COVID-19 illness and treatment decrease bone mineral density of surviving hospitalized patients[J]. Eur Rev Med Pharmacol Sci, 2022, 26(8): 3046-3056.
[2]	Barrea L, Grant WB, Frias-Toral E, et al. Dietary recommendations for post-COVID-19 syndrome[J]. Nutrients, 2022, 14(6): 1305. doi: 10.3390/nu14061305 URL
[3]	Bandeira L, Lazaretti-Castro M, Binkley N. Clinical aspects of SARS-CoV-2 infection and vitamin D: COVID-19 and the endocrine system[J]. Rev Endocr Metab Disord, 2022, 23(2): 287-291. doi: 10.1007/s11154-021-09683-9 URL
[4]	Qiao W, Lau HE, Xie H, et al. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters[J]. Nat Commun, 2022, 13(1): 2539. doi: 10.1038/s41467-022-30195-w pmid: 35534483
[5]	Battisti S, Napoli N, Pedone C, et al. Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency[J]. Endocrine, 2021, 74(3): 461-469. doi: 10.1007/s12020-021-02872-1 URL
[6]	中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华内分泌代谢杂志, 2017, 33(10): 890-913.
[7]	中国营养学会骨营养与健康分会, 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症患者的营养和运动管理专家共识[J]. 中华内分泌代谢杂志, 2020, 36(8):643-653.
[8]	Leandro CG, Ferreira E, Silva WT, et al. Covid-19 and Exercise-Induced Immunomodulation[J]. Neuroimmuno-modulation, 2020, 27(1): 75-78.
[9]	Morais AHA, Aquino JS, da Silva-Maia JK, et al. Nutritional status, diet and viral respiratory infections: perspectives for severe acute respiratory syndrome coronavirus 2[J]. Br J Nutr, 2021, 125: 851-862. doi: 10.1017/S0007114520003311 URL
[10]	杨嫣琼, 张巧, 彭年春, 等. 睡眠时长、入睡时间与绝经后女性骨质疏松风险的相关性研究[J]. 中华内分泌代谢杂志, 2020, 36(11): 949-955.
[11]	di Filippo L, Frara S, Doga M, et al. The osteo-metabolic phenotype of COVID-19: an update[J]. Endocrine, 2022, 78(2): 247-254. doi: 10.1007/s12020-022-03135-3 URL
[12]	Katz J, Yue S, Xue W. Increased risk for COVID-19 in patients with vitamin D deficiency[J]. Nutrition, 2021, 84:111106.
[13]	Elamir YM, Amir H, Lim S, et al. A randomized pilot study using calcitriol in hospitalized COVID-19 patients[J]. Bone, 2022, 154: 116175. doi: 10.1016/j.bone.2021.116175 URL
[14]	Artero A, Tarín JJ, Cano A. The adverse effects of estrogen and selective estrogen receptor modulators on hemostasis and thrombosis[J]. Semin Thromb Hemost, 2012, 38(8): 797-807. doi: 10.1055/s-0032-1328883 pmid: 23111860
[15]	Atmaca A, Demirci I, Haymana C, et al. No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study[J]. Osteoporos Int, 2022, 33(1): 273-282. doi: 10.1007/s00198-021-06067-2 URL
[16]	Lv H, Zhang Q, Yin Y, et al. Epidemiologic characteristics of traumatic fractures during the outbreak of corona-virus disease 2019(COVID-19) in China[J]. Injury, 2020, 51(8): 1698-1704. doi: 10.1016/j.injury.2020.06.022 URL
[17]	Reid IR, Gamble GD, Mesenbrink P, et al. Characterization of and risk factors for the acute-phase response after zoledronic acid[J]. J Clin Endocrinol Metab, 2010, 95(9): 4380-4387. doi: 10.1210/jc.2010-0597 pmid: 20554708
[18]	Letizia AG, Ramos I, Obla A, et al. SARS-CoV-2 transmission among marine recruits during quarantine[J]. N Engl J Med, 2020, 383(25): 2407-2416. doi: 10.1056/NEJMoa2029717 URL
[19]	Blanch-Rubió J, Soldevila-Domenech N, Tío L, et al. Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions[J]. Aging (Albany NY), 2020, 12(20):19923-19937.
[20]	Gonzalez-Rodriguez E, Aubry-Rozier B, Stoll D, et al. Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors[J]. Breast Cancer Res Treat, 2020, 179(1):153-159. doi: 10.1007/s10549-019-05458-8 URL
[21]	Tan YL, Tan KSW, Chu JJH, et al. Combination treatment with remdesivir and ivermectin exerts highly synergistic and potent antiviral activity against murine corona-virus infection[J]. Front Cell Infect Microbiol, 2021, 11: 700502. doi: 10.3389/fcimb.2021.700502 URL
[22]	Wu Q, Zhou X, Huang D, et al. IL-6 Enhances osteocyte-mediated osteoclastogenesis by promoting JAK2 and RANKL activity in vitro[J]. Cell Physiol Biochem, 2017, 41: 1360-1369. doi: 10.1159/000465455 URL

骨质疏松症新型冠状病毒感染临床应对指南

Guidelines for clinical management of novel coronavirus infection in osteoporosis

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 22

相关文章 15

编辑推荐

Metrics

本文评价

[1]	中华医学会内分泌学分会. 老年与儿童青少年糖尿病人群新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 10-12.
[2]	中华医学会内分泌学分会. 甲状腺功能异常新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 13-15.
[3]	中华医学会内分泌学分会. 肾上腺疾病新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 16-17.
[4]	中华医学会内分泌学分会. 垂体疾病新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 18-21.
[5]	中华医学会内分泌学分会. 尿崩症患者新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 25-27.
[6]	李羽　陈林林　何平华. 基于CBCT髁状突体积分析的髁状突骨折后TMJ骨性形态测量[J]. 组织工程与重建外科杂志, 2022, 18(4): 336-.
[7]	刘欣, 綦才辉, 王振竞, 吕娜, 王少婷, 王淑萍. 胰高血糖素样肽-1激动剂Exendin-4 刺激小鼠胚胎成骨细胞前体细胞MC3T3-E1的转录组学体外研究[J]. 诊断学理论与实践, 2022, 21(03): 367-373.
[8]	中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下骨质疏松症管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 133-135.
[9]	黄震韩森东王志伟陈杰. ３Ｄ打印技术在 PHILOS 锁定钢板治疗肱骨近端Neer Ⅲ、Ⅳ型骨折中的应用[J]. 组织工程与重建外科杂志, 2021, 17(6): 545-.
[10]	王绍刚胡龙驹汪东旭陶忠亮. 运用双反牵引联合 PFNA 内固定治疗股骨转子间骨折外侧壁缺损的临床研究[J]. 组织工程与重建外科杂志, 2021, 17(6): 549-.
[11]	顾伟孙骏李志强卫晓恩. 高活动状态老年人桡骨远端骨折功能预后的影响因素[J]. 组织工程与重建外科杂志, 2021, 17(5): 405-.
[12]	周春张妹妹董宇启李鹤冯宇. “秦氏疼痛方”联合单次小剂量地塞米松治疗踝关节骨折后急性软组织损伤的疗效研究[J]. 组织工程与重建外科杂志, 2021, 17(5): 420-.
[13]	李艳李萍殷宗宝陈晓峰薛小云张烨. 急性髋关节骨折患者手术时机的选择[J]. 组织工程与重建外科杂志, 2021, 17(4): 345-.
[14]	马泽涛王德利翁鉴冯松. 复杂Ｃ３型骨盆骨折内固定手术策略及效果分析 [J]. 组织工程与重建外科杂志, 2021, 17(3): 247-.
[15]	倪小君郑佳丽李丽周文君唐诗芸卞薇薇. 应用ＯＨＩＰ－１４评价颌面部骨折患者手术等待期的口腔健康相关生活质量现状并分析影响因素[J]. 组织工程与重建外科杂志, 2021, 17(3): 251-.